Related Experiment Videos
Surgery for recurrent intra-abdominal cancer
Summary
Emergency surgery for recurrent intra-abdominal cancer offers a poorer prognosis than elective surgery. Resective surgery provides the best survival chance in emergencies, despite high risks.
Area of Science:
- Oncology
- Surgical Oncology
- Gastrointestinal Surgery
Background:
- Recurrent intra-abdominal cancer presents significant management challenges.
- Surgical intervention is often necessary but carries inherent risks.
- Comparing emergency versus elective surgical approaches is crucial for optimizing patient outcomes.
Purpose of the Study:
- To compare the outcomes of emergency versus elective surgery in patients with recurrent intra-abdominal cancer.
- To evaluate postoperative mortality, morbidity, survival rates, and symptom relief.
- To identify the most effective surgical strategies for recurrent disease.
Main Methods:
- Retrospective review of 185 patients with recurrent intra-abdominal cancer.
- Categorization of patients into emergency (41) and elective (144) surgical groups.
- Analysis of postoperative mortality, morbidity, survival, and symptom relief data.
Main Results:
- Overall 5-year survival was 5%, with a median survival of 7 months.
- Emergency surgery showed significantly higher mortality (41% vs 13%) and morbidity (68% vs 39%) compared to elective surgery.
- Mean survival was shorter in the emergency group (5 months) versus the elective group (17 months).
- Postoperative sepsis was the leading cause of death in emergency cases; fistula and obstruction in elective cases.
- Resection (33% mortality) and bypass (11% mortality) were associated with lower risk than enterostomy (61% mortality) and laparotomy (50% mortality) in emergencies.
Conclusions:
- Elective surgery for recurrent intra-abdominal cancer is associated with a significantly better prognosis than emergency surgery.
- Resective surgery offers the best chance for improved survival in emergency settings, despite high risks.
- If resection is not feasible, bypass procedures should be considered for recurrent intra-abdominal cancer management.